Advertisements

Iberet 500

Quick links to important sections

Iberet 500

Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Iberet 500

Quick Facts

Property Description
Active ingredients Iron, Ascorbic Acid, and B-Complex Vitamins
Form Film-coated sustained-release oral tablet
Pharmacological class Hematinic Agent, Multivitamin-Mineral Supplement
General Purpose Nutritional support for blood formation and energy metabolism
Origin Synthetic combination of essential nutrients

Iberet 500 is fundamentally a brand-specific combination preparation classified as a Hematinic Agent and a high-potency Multivitamin-Mineral Supplement. Its core purpose is to provide nutritional support by supplying essential micronutrients required for healthy red blood cell formation and fundamental cellular energy metabolism. A key feature of the tablet form is the implementation of sustained-release technology, which controls the liberation of the active ingredients over an extended period, differentiating it from conventional immediate-release iron supplements.

What Pharmacological Class Does Iberet 500 Belong To?

Iberet 500 belongs to the Hematinic Agent class, encompassing substances that facilitate the formation of blood components, alongside its designation as a Multivitamin with Iron. The preparation is a synthetic combination of essential nutritional factors, positioning it as an oral supplement for targeted support rather than a single-entity drug. Its high-potency profile is structurally distinct, specifically combining a therapeutic dose of Iron with a broad spectrum of necessary B-group vitamins and Vitamin C.

Iberet 500 Composition and Dosage Form

The product is supplied as a film-coated sustained-release oral tablet, containing elemental Iron (as a ferrous salt) and a blend of eight vitamins. The composition includes high levels of Ascorbic Acid (Vitamin C), which is used for enhancing the absorption and bioavailability of the non-heme iron component. The full Vitamin B complex (including Thiamine, Riboflavin, Niacinamide, Calcium Pantothenate, Pyridoxine, and Cyanocobalamin) is also integrated. The sustained-release property is integral to the product's identity, ensuring a controlled, gradual delivery of the active ingredients.

General Purpose of Iberet 500

The general function of Iberet 500 is to support the body’s ability to conduct crucial metabolic and blood-related processes. The Iron supplies the critical component for hemoglobin synthesis, while the Vitamin B complex components serve as indispensable cofactors in cellular energy conversion. This strategic combination is used to maintain a steady supply of these combined essential nutrients to fortify red blood cell formation and overall physiological vitality.

Advertisements

What side effects are possible with Iberet 500?

Possible Side Effects and Safety Information

The safety profile for this medicine is based on official regulatory documentation and clinical data.

Adverse Reactions and System-Organ Effects

The most commonly reported side effects involve the Gastrointestinal System. These effects are generally considered dose-related and may include:

  • Nausea
  • Constipation
  • Diarrhea
  • Abdominal pain or upset stomach
  • Heartburn
  • Vomiting

Iron preparations, including this one, may cause stools to appear darker in color (black or green), which is typically not considered a cause for concern in the absence of other symptoms. However, regulatory documentation notes that iron oral preparations may rarely cause false-positive results in fecal occult blood tests.

Serious Adverse Reactions

Although rare, certain clinically significant and serious adverse reactions have been documented:

  • Hypersensitivity/Allergic Reaction: Severe allergic reactions may occur. Symptoms can include rash, hives, severe dizziness, or difficulty breathing, which requires immediate medical attention.
  • Iron Overload: Secondary hemochromatosis or hemosiderosis (iron overload) has been reported rarely, typically following prolonged administration or in patients with pre-existing conditions that increase iron absorption.

Population-Specific Safety Considerations

The most stringent regulatory warning is related to accidental ingestion in children:

  • Pediatric Risk: Accidental overdose of iron-containing products is cited as a leading cause of fatal poisoning in children under 6 years of age. This safety information mandates that the product be kept out of the reach of children.
  • Pre-existing Conditions: Caution is advised for patients with existing iron overload disorders (such as hemochromatosis or hemosiderosis) or with certain underlying conditions that augment iron absorption.

The safety information above is derived from authoritative government regulatory documents and is not a complete list of every possible reaction. It structures the understanding of the medicine's risks by detailing common expected effects, rare serious risks, and critical population-specific warnings.

Advertisements

Overdose and Emergency Response

Iberet 500 Overdose and When to Seek Help

Iberet 500 contains iron (as ferrous sulfate) and Vitamin C (as ascorbic acid), with the primary risk of severe toxicity stemming from iron overdose. Acute iron poisoning, especially in children, is a serious medical emergency and can be fatal. The typical course of severe iron poisoning often occurs in stages. Initial symptoms, usually within six hours of ingestion, include gastrointestinal distress such as vomiting, severe abdominal pain, and diarrhea, which may be bloody.

Following the initial symptoms, a deceptive period of apparent improvement, known as the quiescent stage, may occur before more severe systemic toxicity manifests. Later, symptoms can progress to involve low blood pressure (shock), metabolic acidosis, liver failure, and coma. Long-term complications, such as gastrointestinal scarring, may also develop.

When to Seek Immediate Medical Help

Always seek emergency medical attention or contact a poison control center immediately if an overdose of Iberet 500 is suspected, regardless of whether symptoms are present. Do not wait for symptoms to worsen or resolve.

Call for emergency help if the person exhibits any of the following signs:

  • Severe or persistent vomiting or diarrhea
  • Vomiting blood or passing black, tarry, or bloody stools
  • Significant drowsiness, lethargy, or confusion
  • Pale, clammy skin, rapid pulse, or other signs of shock
  • Difficulty breathing or seizures

Early medical intervention is critical for managing iron toxicity.

Advertisements

Therapeutic Uses of Iberet 500

What Iberet 500 Treats: Main Uses and Benefits

Iberet 500 is commonly used to help with symptoms related to systemic imbalance. The product is considered relevant for easing symptoms that interfere with daily comfort. It is applied across domains where additional symptomatic support is needed due to conditions involving episodic or fluctuating manifestations.


Key Areas of Symptom Management

Iberet 500 is relevant for use in conditions characterized by periods of heightened symptoms, helping to address symptom clusters that may become intense or disruptive, such as those that create noticeable physiological strain. It provides support that helps ease the overall symptom burden during phases of increased distress or discomfort. The product assists with maintaining functional stability when symptoms interfere with routine activities.

“It offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.”


Quick Fact

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Iberet 500 contributes to improved comfort during periods of heightened symptoms, and is relevant when supportive symptom management is appropriate.

Regulatory References

  1. NHS guidance on iron deficiency anaemia
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

The use of Iberet 500 is defined by regulatory bodies for specific patient populations. The medicine is intended for use in non-pregnant adults and pregnant adults to address certain nutritional needs.


Eligibility Status Population / Condition Regulatory Classification
Allowed Non-pregnant adults, pregnant adults Indicated Population
Contraindicated Pediatric patients (children under 6) Use Not Established / Risk of Poisoning
Contraindicated Iron overload disorders (e.g., hemochromatosis, hemosiderosis, thalassemia, sideroblastic anemia) Excluded Population
Contraindicated Known hypersensitivity to any component (including folic acid) Excluded Population
Contraindicated Pernicious anemia Excluded Population

Iberet 500 is strictly contraindicated and must not be used by individuals with certain iron-excess conditions, such as hemochromatosis or hemosiderosis, due to the risk of iron accumulation. It is also contraindicated for patients with a known hypersensitivity to any ingredient, or those diagnosed with pernicious anemia, as the folic acid component may mask the progression of that condition. Furthermore, the product is not for use in pediatric patients.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes documented interactions between Iberet 500 (Multivitamin with Iron) and other medicinal products or substances, based on official government regulatory information.

Interactions primarily involve a reduction in the bioavailability and absorption of either the components of Iberet 500 or the co-administered medication.

Medicinal Product Categories with Documented Interactions

The following categories of medicinal products have been associated with altered absorption when used concomitantly with iron-containing products, as stated in regulatory labels:

  • Antibiotics: Including quinolone antibiotics (such as ciprofloxacin and levofloxacin) and tetracycline antibiotics (such as doxycycline and minocycline).
  • Bone Health: Bisphosphonates, such as alendronate.
  • Thyroid Medications: Including levothyroxine.
  • Parkinson's Disease Treatment: Levodopa.
  • Anti-rheumatic Agents: Penicillamine.

For these interacting drugs, the principal constraint involves temporal separation of administration to minimize the risk of decreased effectiveness for both agents. The iron component may interfere with the uptake of these medications, and conversely, the medications may impair the absorption of iron.

Non-Medicinal Substances and Timing Requirements

Official documents indicate that the absorption and effectiveness of this product can be reduced by several common, non-medicinal substances. Antacids, dairy products, coffee, and tea should be avoided within a two-hour window before or after administration to prevent decreased bioavailability.

Advertisements

Mechanism of Action

How Iberet 500 Works: Biological Mechanisms

Enhanced Iron Bioavailability and Transport Pathways

This mechanism primarily involves the synergistic action of ferrous sulfate and ascorbic acid (Vitamin C). The Vitamin C maintains iron in its readily absorbed Fe^2+ state, facilitating its uptake through Divalent Metal Transporter 1 (DMT1) on duodenal enterocytes. This supports the systemic delivery of iron via transferrin, which precedes incorporation into metabolic components.


Cofactor Modulation of Red Blood Cell Synthesis

Iberet 500 contains essential B-vitamins, including Folic Acid (Vitamin B9) and Vitamin B12, which function as critical cofactors within the one-carbon metabolic pathways. These pathways are crucial for the synthesis of DNA building blocks, directly supporting the division and maturation of erythroid cells in the bone marrow. This targeted support of cell proliferation establishes systemic oxygen transport capacity.


Supporting Key Enzyme Systems and Energy Metabolism

The delivered micronutrients (iron and various B-vitamins) are integrated into the architecture of numerous enzyme systems, including the cytochromes of the mitochondrial electron transport chain. The delivery of these micronutrients facilitates the action of enzymes central to cellular respiration and energy-producing pathways (like the Krebs cycle).

Advertisements

Dosage and Administration Information

Iberet 500 is a high-potency hematinic agent for oral administration only, supplied as a film-coated sustained-release tablet containing elemental iron and multiple vitamins. The use of this medicine is structured around a standard adult regimen based on the prescribed daily intake of one tablet.


Administration Dosing and Frequency

The standard administration schedule is once daily, with the recommended dosage being one tablet. This pattern establishes a continuous regimen to supply 105 mg of elemental iron and 500 mg of Ascorbic Acid. The standard adult dose is generally applied to pregnant females, although pediatric administration requires separate clinical guidance.


Procedural Use and Timing

Due to the sustained-release nature of the tablet, procedural constraints are critical for correct use. The tablet must be swallowed whole with water and must never be crushed, split, or chewed, as this would interfere with the controlled release of the medication. The timing of intake is flexible: while maximum absorption occurs when taken on an empty stomach, the tablet may be taken with food if needed to mitigate gastrointestinal discomfort. A special procedural condition is that patients should avoid lying down for at least 10 minutes after administration.


Handling Missed Doses

If a scheduled dose is missed, it should be taken as soon as remembered. However, if the time is near the next scheduled dose, the missed dose should be skipped entirely, and the normal once daily schedule should resume. A double dose must never be taken to make up for a missed one. The duration of use is guided by the underlying requirement for nutritional support, not by a fixed cycle.

Advertisements

Recent Clinical Evidence

Clinical Evidence Supporting Combination Therapy

Iberet 500 is a fixed-dose combination product containing ferrous sulfate (an oral iron salt), ascorbic acid (Vitamin C), and B-complex vitamins (including Folic Acid and Vitamin B12). The research evidence for its use is based on the established clinical utility of its individual components in addressing nutritional deficiencies.


Ferrous Sulfate for Iron Deficiency

Ferrous sulfate is the most commonly prescribed and studied oral iron replacement therapy for iron deficiency anemia (IDA). Clinical trials consistently report that oral ferrous iron supplements, when administered appropriately, are effective in increasing hemoglobin and replenishing iron stores (measured by serum ferritin) in both adult and pediatric patients with IDA. Studies indicate that improvements in hemoglobin levels may be observed within weeks of initiating treatment.

Role of Ascorbic Acid

Ascorbic acid (Vitamin C) is included in the formulation due to its established property as an enhancer of non-heme iron absorption. Research suggests that Vitamin C can facilitate the uptake of non-heme iron in the gastrointestinal tract, primarily by chemically reducing ferric iron (Fe^3+) to the more readily absorbed ferrous form (Fe^2+). While some high-quality trials suggest the clinical benefit of adding high-dose Vitamin C to oral iron may be minor in certain populations, its chemical role in enhancing absorption remains undisputed.

B-Complex and Folic Acid

The B-complex vitamins, particularly Folic Acid (Vitamin B9) and Cyanocobalamin (Vitamin B12), are included to address concurrent nutritional deficiencies. Folic acid and Vitamin B12 play essential roles in red blood cell formation and DNA synthesis. Supplementation with these B vitamins is particularly relevant for the management of megaloblastic anemia and in patient groups with increased nutritional requirements, such as pregnant women.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Iberet 500 (FAQ)


Q: What is the '500' in the name referring to?

A: The '500' in the product name refers to the quantity of ascorbic acid, or Vitamin C, present in each tablet. The official product information specifies that each sustained-release tablet contains 500 mg of this component. Vitamin C is included in the formulation because of its established role in enhancing the body's absorption of the non-heme iron component.


Q: Is Iberet 500 the same as other iron pills like ferrous sulfate?

A: Iberet 500 is not the same as a single-entity ferrous sulfate tablet. While it does contain ferrous sulfate as its source of iron, it is classified in regulatory documents as a combination product. This means it also includes a therapeutic dose of Ascorbic Acid (Vitamin C) and multiple B-complex vitamins, features that differentiate it from plain iron supplements.


Q: Does the package insert for Iberet 500 list any long-term side effects?

A: The official product information lists that iron overload conditions, such as hemosiderosis or hemochromatosis, have been reported rarely. These effects are typically associated with prolonged administration or may occur in patients who have pre-existing conditions that increase their absorption of iron.


Q: What happens if I forget to take a dose of Iberet 500?

A: Official guidance on handling missed doses states that if the time is near the next scheduled dose, the missed dose should be skipped entirely, and the normal schedule should resume. Regulatory sources consistently advise against taking a double dose to make up for a missed one.


Q: What are the symptoms of an overdose of iron supplements like Iberet 500?

A: Acute overdosage with iron-containing products can initially cause symptoms such as nausea and vomiting. Official warnings indicate that in severe cases, symptoms can progress to clinically significant issues, including cardiovascular collapse or shock. The official warning indicates that immediate medical attention should be sought in the case of a suspected overdose.


Q: Can Iberet 500 be used by people with a history of alcohol abuse?

A: Regulatory documentation advises individuals to inform their healthcare provider of their complete medical history, which specifically includes a history of use or abuse of alcohol or any existing liver problems. This disclosure is necessary for a comprehensive review of the individual's medical profile.


Q: Is Iberet 500 considered a standard iron supplement?

A: According to official documentation, Iberet 500 is classified as a high-potency multivitamin-mineral supplement and a hematinic agent. This classification emphasizes that it is a specific combination of iron and multiple vitamins, setting it apart from a standard, single-ingredient iron supplement.


Q: Does Iberet 500 help with feeling tired?

A: The official purpose of Iberet 500 is to provide nutritional support by supplying essential micronutrients required for blood formation and cellular energy metabolism. The components are described as providing nutritional support for physiological vitality and cellular energy metabolism.


Q: How long does it typically take before effects of Iberet 500 are noticed?

A: Clinical trial summaries for oral ferrous iron supplements, which is the type of iron in Iberet 500, indicate that improvements in key blood markers like hemoglobin levels may be observed within weeks of starting treatment.


Q: What should I do if I think I've taken too much Iberet 500?

A: Official regulatory warnings emphasize that in the case of accidental overdose of iron-containing products, the warning advises contacting a doctor or a poison control center immediately. Iron products carry a stringent warning regarding the seriousness of accidental ingestion, especially in children.


Q: Is Iberet 500 only for iron deficiency or is it for general vitamin deficiency too?

A: Official documentation indicates that this medicine is used to treat or prevent a vitamin deficiency that may be caused by a poor diet, certain illnesses, or specific life stages like pregnancy, in addition to addressing the body's iron requirements.


Q: What is the relationship between vitamin B complex in Iberet 500 and energy levels?

A: The B-complex vitamins included in the formulation support cellular energy processes. They are described in official texts as facilitating the action of enzymes that are central to cellular respiration and the body's major energy-producing pathways.


Q: Is there a difference between Iberet 500 and the Chewable Iberet?

A: Iberet 500 is officially supplied as a film-coated sustained-release oral tablet. This dosage form has specific release characteristics and administration instructions that differ from a chewable tablet.


Q: Is Iberet 500 suitable for children?

A: Iberet 500 is strictly contraindicated, or advised against, for use in pediatric patients (children under 6). Official regulatory warnings cite the risk of fatal iron poisoning from accidental overdose in children under 6 as the reason for this contraindication.


Q: Do official sources describe Iberet 500 as a treatment for restless legs syndrome?

A: No. The official indications for Iberet 500, as stated in regulatory documents, relate to nutritional support for blood formation and energy metabolism due to deficiency. They do not include the treatment or management of Restless Legs Syndrome.


Q: Are there any specific warnings about taking Iberet 500 with dairy products?

A: Yes, official documents warn that dairy products should be avoided within a two-hour window before or after administration of the tablet. This timing constraint is advised because dairy can potentially reduce the absorption and overall effectiveness of the product.

--=

Q: What is the difference between iron deficiency and iron-deficiency anemia as they relate to Iberet 500 use?

A: Regulatory texts refer to the established use of the iron component in addressing iron deficiency anemia (IDA). IDA is a condition where the iron deficiency is severe enough to cause reduced hemoglobin levels, while iron deficiency refers to a lower-than-normal store of iron in the body.


Q: Are there warnings about Iberet 500 use in people with stomach ulcers?

A: Regulatory documents advise patients to inform their healthcare provider of their complete medical history, especially any existing stomach or intestinal problems such as ulcers or colitis, before using the medicine.


Q: Why are some ingredients in Iberet 500 called 'therapeutic B-complex'?

A: The B-complex vitamins in Iberet 500 are referred to as 'therapeutic' due to the product's official classification as a high-potency multivitamin-mineral supplement. This indicates that the product delivers a specific, high-level blend of B-group vitamins intended for nutritional support.


Q: Can people with diabetes use Iberet 500?

A: Regulatory documents do not list diabetes as a contraindication for use. However, if the product contains folic acid, patients with conditions like pernicious anemia (a type of Vitamin B12 deficiency) should inform their doctor, as folic acid can potentially affect certain lab tests related to B12 deficiency.


Q: Is there any research on how well Iberet 500 is absorbed by the body?

A: Official product information addresses absorption by explaining the roles of certain components. It highlights the function of Ascorbic Acid (Vitamin C) in chemically enhancing iron absorption and the purpose of the sustained-release property in controlling the rate of ingredient delivery within the body.


Q: Do official documents specify if Iberet 500 can be broken or crushed?

A: Yes. Official procedural guidelines state that the tablet must be swallowed whole and must not be crushed, split, or chewed, as this would interfere with the controlled-release mechanism.

Advertisements

How should Iberet 500 be stored and disposed of?

Official Storage and Disposal Requirements

Iberet 500 must be stored strictly according to the conditions defined in the official regulatory product information to ensure its stability and potency up to the labeled expiration date.

Storage Constraints:

  • Temperature: Store the product at or below 30 C.
  • Environment: The container must be kept closed, and the product protected from exposure to direct heat, strong sunlight, and moisture.
  • Safety: The most critical storage instruction is to keep Iberet 500, like all iron-containing products, safely out of the reach and sight of children and animals to prevent accidental overdose.

Handling and Disposal:

The product must not be used after the expiration date printed on the container. Standard disposal instructions mandate discarding any unused or expired medicine according to local governmental guidelines for pharmaceutical waste. No special handling is typically required beyond maintaining the integrity of the container during storage.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Iberet 500 found in:

A-Z Index: